Sol Langermann
Equibles does not estimate personal net worth.
About Sol Langermann
The proxy statement of NextCure, Inc. reports total compensation of $990,524 for Sol Langermann in fiscal 2022, including a base salary of $432,242. Disclosed compensation is on record for 5 fiscal years.
Affiliation history
-
NextCure, Inc. (NXTC)
Proxy statement
Start not stated–2024-04-26
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | NextCure, Inc. (NXTC) | Chief Scientific Officer | $432,242 | $990,524 |
| 2021 | NextCure, Inc. (NXTC) | Chief Scientific Officer | $406,350 | $1,392,982 |
| 2020 | NextCure, Inc. (NXTC) | Chief Scientific Officer | $372,673 | $2,484,687 |
| 2019 | NextCure, Inc. (NXTC) | Chief Scientific Officer | $351,633 | $459,105 |
| 2018 | NextCure, Inc. (NXTC) | Chief Scientific Officer | $340,976 | $882,291 |
Recent activity
No call appearances or filed executive changes recorded yet.